Wall Street's Augury: Sequenom Inc. (Nasdaq:SQNM)
Sequenom has completed the sale of its Bioscience business to Agena Bioscience
Las Vegas, NV (I-Newswire) May 31, 2014 - Keep a close eye on Sequenom, Inc. (SQNM). After the closing bell on Friday, the company reported that it has completed the sale of its Bioscience business to Agena Bioscience, Inc., a portfolio company of Telegraph Hill Partners.
Agena Bioscience also assumed certain liabilities related to the Bioscience business, which does not include any portion of SQNM's bank debt or convertible notes outstanding. The facility lease for its Bioscience location in San Diego was also assumed by Agena Bioscience.
The terms of the agreement provide for a purchase price of $31.8 million, subject to certain adjustments, and SQNM may also receive up to $4 million in contingent consideration upon the achievement of certain regulatory and sales milestones.
Furthermore, William Welch, President and Chief Operating Officer, and Carolyn Beaver, Vice President and Chief Accounting Officer, will present at the Jefferies 2014 Global Healthcare Conference on Tuesday, June 3, 2014 beginning at 2:00 p.m. ET in New York City to provide an overview of and update on the Company.
The presentation is expected to last approximately 30 minutes and will be webcast live through the "Invest" section of the SQNM Web site. An audio replay will be available for 30 days following the initial broadcast.
SQNM is a life sciences company committed to improving healthcare through revolutionary genomic and genetic analysis solutions. The company develops innovative technology, products and diagnostic tests that target and serve molecular diagnostic markets.
More about Sequenom, Inc. (SQNM) at www.sequenom.com
CRWE-PR Finance www.finance.crwe-pr.com/2014/05/31/wall-streets-augury-sequenom-inc-nasdaqsqnm
Read Full Disclaimer at www.finance.crwe-pr.com/disclaimer
About Finance CRWE-PR
11226 Pentland Downs Street
Las Vegas, NV
Tags:Wall Street Augury Sequenom Nasdaq:SQNM SQNM genetic analysis genomic analysis molecular diagnostic
Published On:May 31, 2014
Print Release:Print Release
If you have questions regarding information in this press release contact the company listed above. I-Newswire.com is a press release service and not the author of this press release.The information that is on or available through this site is for informational purposes only and speaks only as of the particular date or dates of that information. As some companies and PR Agencies submit their press releases once per week,month or quarter, make sure to check the official company website for accurate release dates as our site displays the I-Newswire.com press release distribution date only.We do not guarantee the accuracy or completeness of information on or available through this site, and we are not responsible for or omissions in that information or for actions taken in reliance on that information.
LaSalle Network Named a Fastest-Growing Staffing Firm by Staffing Industry Analysts for 2014
Puma Biotechnology (PBYI) Wins a Battle on the Breast-Cancer War
Marketing Question And Answer Webinar Scheduled For Wednesday The 23rd Of July
The Ballen Group Is Selling A Las Vegas Home In Craig Est
Summerlin Home In Corta Bella For Sale By The Ballen Group Reduces It's Price By $20,000